Anxiety screening outreach: Task Force age groups, crisis lines, online self-checks, coverage and calming claims

Anxiety screening outreach invites patients who have not been asked about worry, fear or panic to talk about it as part of routine care. NIMH says anxiety disorders involve more than occasional worry or fear, yet a person may treat constant worry as part of who they are or may not know that care exists. The outreach is worth doing and easy to get wrong. A page can promise calm in minutes, put a free online anxiety test on a public page that sends the answers to an ad tool, invite a six year old to a screening the Task Force has not recommended for that age, treat chest pain as panic, or leave out the line a reader in crisis needs. This guide covers what the federal sources say, the age groups, crisis and emergency wording, online self-checks, what happens after a positive screen, coverage, products, reminders, minors and families, partners, privacy and tone.

Related topics have their own guides and are not repeated here. Mood screening is covered in our guide to depression screening outreach, which also covers online self-checks in detail, and screening during and after pregnancy in our guide to perinatal depression outreach. Care after a positive screen is covered in our guides to psychiatric practice marketing, therapist private practice marketing and behavioral health integration outreach, and children’s care in our guides to pediatric practice marketing and school-based health center marketing.

What the federal sources say

The USPSTF rates preventive services for people without symptoms, HRSA publishes the women’s preventive services guidelines that plans cover, NIMH and MedlinePlus explain anxiety to patients, and Medicare.gov publishes what Part B pays for. The points that shape anxiety screening outreach:

• The USPSTF final recommendation Anxiety Disorders in Adults: Screening (June 20, 2023) recommends screening for anxiety disorders in adults 64 years or younger, including pregnant and postpartum persons (grade B). For adults 65 or older it issues an I statement: the evidence is insufficient to assess the balance of benefits and harms. It applies to adults 19 or older who do not have a diagnosed mental health disorder and are not showing recognized signs or symptoms of anxiety disorders.
• The same recommendation says screening tools alone are insufficient to diagnose anxiety disorders and that a positive result needs a confirmatory diagnostic assessment. It says there is little evidence on the best timing or interval, and describes a pragmatic approach of screening adults who have not been screened before and using clinical judgment on further screening. It says treatment can include psychotherapy or medicine, and that people who screen positive should be evaluated further and, if appropriate, provided or referred for evidence-based care.
• The USPSTF final recommendation Anxiety in Children and Adolescents: Screening (October 11, 2022) recommends screening for anxiety in children and adolescents aged 8 to 18 (grade B), and issues an I statement for children 7 or younger. It applies to youth without a diagnosed anxiety disorder and without recognized signs or symptoms of anxiety, says the Task Force found no evidence on the right screening interval, and says a positive result needs a confirmatory diagnostic assessment and follow-up. For children 7 or younger, it says clinicians should use their judgment based on the individual child.
• The HRSA Women’s Preventive Services Guidelines page (last reviewed December 2025, read through an archived copy) includes a recommendation for screening for anxiety in adolescent and adult women, including those who are pregnant or postpartum, and says optimal intervals are unknown and clinical judgment should set the frequency.
• The NIMH page Anxiety Disorders (last reviewed December 2024) says feeling anxious is a normal part of life, that anxiety disorders involve more than occasional worry or fear, and that for people with these disorders anxiety does not go away, is felt in different situations and can get worse over time. It names generalized anxiety disorder, panic disorder, social anxiety disorder and phobia-related disorders. The MedlinePlus page Anxiety (updated October 17, 2023) describes anxiety as a feeling of fear, dread and uneasiness.
• Medicare.gov says Part B covers one depression screening each year in a primary care setting that can provide follow-up treatment and referrals, and that outpatient mental health care, which the page describes as diagnosing and treating conditions such as depression, anxiety and substance use disorder, is covered under Part B. We could not find a separate Medicare preventive benefit for anxiety screening on Medicare.gov on October 30, 2026.

We checked for changes before writing. Neither USPSTF page carries an update in progress notice, and the USPSTF Recommendations in Progress page, checked October 30, 2026, lists no anxiety topic; we could not confirm developments after that date. The Task Force itself has changed. In Kennedy v. Braidwood Management, decided June 27, 2025, the Supreme Court held that Task Force members are inferior officers whose appointment by the Secretary of HHS is consistent with the Appointments Clause. On September 17, 2026, HHS announced eight new members who join the eight already serving. Both anxiety recommendations were issued before that change, so check the USPSTF pages again before a campaign runs.

Two points shape the marketing. First, a screen is a few questions, not a diagnosis: the page can say the care team asks about worry and stress as part of routine visits, and should not tell a reader they have an anxiety disorder or promise one will be found or ruled out. Second, the recommendations cover people without symptoms. A reader who already feels anxiety every day does not need a screening invitation; they need an appointment, and the page should say plainly how to get one.

Anxiety pages and claims that need rewriting

Google’s search suggestions, which we checked on October 30, 2026, offer “anxiety test free online”, “anxiety test free results”, “anxiety screening for teens”, “anxiety screening for 6 year old”, “anxiety screening near me” and “anxiety test cost”. Readers want a quick answer, a price and a place, and parents are searching for young children. A page can give a place and a price honestly, and should leave the answer to a visit.

A page that holds up says in plain words that worry is a normal part of life and that anxiety that does not go away is worth talking about, what the screen involves (a short set of questions at a visit), who it is for according to the USPSTF pages it names and dates, what it costs or how coverage works, that a clinician talks through the answers and what comes next, and how to book. It names the clinicians who do the work.

Phrases that need rewriting:

• “Find out in 2 minutes if you have an anxiety disorder.” A questionnaire does not diagnose; the USPSTF says a positive screen needs a diagnostic assessment. Say the questions help the care team decide whether to look further.
• “Feel calm again in minutes.” A promise of fast relief is a treatment claim the practice would need to substantiate, and it sets up a patient to feel they failed. Describe the care the practice offers, not how fast a person will feel better.
• “Get your anxiety medication online today.” No page should promise a prescription. Say the clinician talks through options, which can include counseling, medicine or a referral.
• “Anxiety screening for kids of every age.” The USPSTF recommends screening from age 8 and found the evidence insufficient for children 7 or younger. A page for young children can invite parents to raise concerns at a visit and should not present screening of young children as recommended.
• “Stop panic attacks for good.” A promise that a program, a technique or a product ends a condition is a claim the practice would need to substantiate, and the word cure belongs nowhere on the page.
• “Natural anxiety relief without medicine.” Presenting a supplement, a tea, an app or a device as a replacement for care a clinician recommends is a treatment claim and can lead a patient to stop care.
• “Anxious? You’re not crazy.” Words like that repeat the stigma they mean to push back on. Plain, calm words work better.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. Quoting the federal sources as written, with each one named and dated, stays inside that standard; turning a screening recommendation into a promise of relief does not.

988, 911 and chest pain on every page and in every tool

An anxiety page is read by people who feel fine, by worried parents and partners, and by people who are struggling right now. Medicare.gov’s mental health pages put the lines where they belong: if you or someone you know is in crisis, call or text 988 or chat at 988lifeline.org, and call 911 if you are in immediate medical crisis. Put those two lines above the booking button, on flyers, on waiting room posters and in reminders, and use 988 as the only crisis number on the page.

Anxiety pages need one more line. MedlinePlus says anxiety might cause a person to sweat, feel restless and tense, and have a rapid heartbeat, and a reader with chest symptoms cannot tell from a web page whether the cause is anxiety or their heart. The CDC page Heart Attack Symptoms, Risk, and Recovery (October 24, 2024, read through an archived copy) lists chest pain or discomfort and shortness of breath among the symptoms and says to call 9-1-1 immediately if you notice the symptoms of a heart attack. A page about panic should say: if you have chest pain, trouble breathing or feel faint, call 911; do not assume it is anxiety. A page should never tell a reader that chest pain is “just anxiety”.

The same wording belongs in voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools. A tool should send any message that mentions suicide, self-harm or a danger to someone’s life to 988 and 911 at once and alert staff, give 911 to any message about chest pain or trouble breathing, pass questions about symptoms or medicines to a clinician, and never tell a person whether they have an anxiety disorder, whether a symptom is panic, or whether to start, change or stop a medicine. Our guides to the AI chatbot on a practice website and answering service versus AI receptionist cover how tools hand off these messages.

Online anxiety tests and self-checks

“Anxiety test free online” is a search people make, and a self-check on a practice site can bring them to care. It also collects sensitive answers on a form nobody watches in real time. Our guide to depression screening outreach sets out the full list of steps for an online self-check; the points that matter for anxiety:

• Say at the top that the self-check is not a diagnosis and does not replace a visit, and put the 988, 911 and chest pain lines above the first question.
• Have the practice’s clinicians choose the questions and approve the wording, and record who approved it and when. Do not copy a questionnaire onto the site without checking who holds the rights to it and whether its terms allow that use.
• Do not label the reader by score (“you have severe anxiety”). Say the answers suggest it would be worth talking with a clinician, and that the care team will ask more questions.
• Show 988 and 911 on every result screen, whatever the score, with a way to book or call.
• Keep the self-check for adults unless the practice’s counsel has approved a version for teens, and do not offer one for young children.
• Do not save or send answers unless the person chooses to, and do not pass answers, scores or the result page address to analytics or ad tools; our guide to tracking pixels on practice websites covers the setup.

Who to invite: children, teens, adults and older adults

The two USPSTF recommendations draw age lines, and each group needs its own wording.

• Children 7 or younger: the USPSTF found the evidence insufficient. Do not run a screening campaign for this age. A pediatric page can say parents are welcome to raise worries about their child at any visit and the clinician will decide what to ask.
• Children and teens 8 to 18: the grade B recommendation covers them. Address the teen as well as the parent, explain that the care team may talk with the teen privately for part of the visit, and say that who may see a minor’s health information depends on state law. A school or sports form visit is a natural time to ask, so long as the form visit is not used to sell other services.
• Adults 19 to 64, including pregnant and postpartum patients: the grade B recommendation covers them. Present the questions as part of routine care, not a sign something is wrong. Our guides to OB-GYN practice marketing and perinatal depression outreach cover visits during and after pregnancy.
• Adults 65 or older: the USPSTF issued an I statement for anxiety screening at this age, while its depression recommendation covers older adults. A page for older patients can invite them to talk about worry and mood at a yearly visit, and should not present anxiety screening as a recommended service. Medicare.gov says that if a provider at a yearly wellness visit thinks a patient may have cognitive impairment, Medicare covers a separate visit that can check for conditions such as dementia, depression, anxiety or delirium; our guide to annual wellness visit outreach covers that visit.
• Patients already in care for anxiety: the recommendations do not cover them. Their follow-up belongs with their care team, not a screening campaign.

Do not select patients for an anxiety message by a diagnosis, a medicine on their chart or a life event pulled from records. Invite by age group and visit type, and let the questions at the visit do the rest.

After the screen: follow-up care and what the page can promise

A positive screen leads to a conversation, not a label. A page can describe the next steps in plain words: the clinician talks through the answers, may ask more questions or schedule a longer visit, and talks through options, which can include counseling, medicine, a referral to a therapist or psychiatrist, or a check on other causes. The USPSTF says treatment can include psychotherapy or medicine; say that the clinician and the patient decide together, and name no medicine.

Only promise what the practice can deliver. If the practice has a therapist on site or a behavioral health team, say so and say how soon a first visit can be booked if the practice knows that. If it refers out, say it helps patients find a clinician their plan covers, and do not promise a wait time it does not control. A page that invites screening without a path to care sends a patient a result and no next step. A practice that offers care by video can say so; our guide to telehealth marketing for practices covers the rules on prescribing and state licensure.

Coverage: preventive rules, women’s guidelines and Medicare

Under 42 U.S.C. 300gg-13, group health plans and health insurers must cover, without cost sharing, services with a USPSTF A or B rating in effect and, for women, the preventive care and screenings in the HRSA supported guidelines. Adult anxiety screening to age 64 and screening for children and teens 8 to 18 both carry a grade B, and the HRSA guidelines include anxiety screening for adolescent and adult women. How a plan applies the rule depends on the plan, the network and how the visit is billed, and a follow-up visit for care is not a preventive service. Keep the recommendation and the coverage apart on the page, and say the practice checks coverage first.

For Medicare patients, do not promise free anxiety screening. Medicare.gov lists one depression screening each year in primary care with no cost to the patient if the provider accepts assignment, and covers outpatient mental health care, which can carry a copayment or coinsurance. We could not confirm a separate anxiety screening benefit. Medicare.gov also tells patients to ask their doctor why a service is recommended and what Medicare will cover. Our guide to marketing to Medicare patients covers the wider rules.

A free screening event or a gift for coming in follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and that the terms of the offer should be stated at the outset. Under 42 U.S.C. 1320a-7a(a)(5), civil penalties can apply to a person who offers or transfers remuneration to a Medicare or state health care program beneficiary that the person knows or should know is likely to influence the beneficiary to order or receive items or services from a particular provider, practitioner or supplier. A free event that feeds paid therapy visits, or a gift card for coming in, needs counsel’s review before it runs.

Supplements, apps and calming products sold alongside

A practice may be offered calming supplements, teas, weighted products, breathing apps or wearable devices to sell or promote next to an anxiety program. The FDA Questions and Answers on Dietary Supplements says supplements are not intended to treat, diagnose, mitigate, prevent or cure diseases. Name no product, make no claim that a supplement, an app or a device treats or prevents anxiety or panic, and do not present any of them as a replacement for care. An app or a device that claims to treat a mental health condition raises FDA device questions the maker has to answer, not the practice; check with counsel before the practice endorses one. Our guide to selling supplements in a medical practice covers the rules on sales.

Recall texts, letters and reminders

Screening reaches patients through recall lists: adults due for a yearly visit, teens due for a checkup, and patients after a pregnancy. Under 45 CFR 164.501, a communication about the practice’s own treatment for an individual, such as a reminder to come in for a recommended service, can fall outside the definition of marketing, while a message that promotes a third party’s product or service generally needs a signed authorization under 45 CFR 164.508. A reminder about the practice’s own visit is not the same as a message that sells a partner’s app or supplement.

The words matter as much as the rule. A text, a postcard or a voicemail can be seen by a partner, a parent or a coworker. Keep these points:

• Invite to the visit, not to the screening: “[Practice name]: you are due for your yearly visit. Call [phone] or reply to book.” Leave the words anxiety, panic, mental health and screening result out of texts, postcards, voicemails and email subject lines.
• Never put a score, a diagnosis or a medicine in a reminder; share results through the portal or a call, as the practice’s protocol says.
• Send teen reminders in the way counsel has approved for minors; 45 CFR 164.502(g) defers to state and other law on when a parent acts as a minor’s personal representative.
• Use the contact method and number the patient chose, and keep the caller ID and the sender name neutral.
• Give each message an easy opt-out, and honor it.

Our guides to text message appointment reminders and the patient recall system cover consent, timing and opt-outs.

Parents, partners and who may hear what

Parents search for anxiety screening for their child and partners call to book for someone else. Under 45 CFR 164.510(b), a covered entity may share information relevant to a family member’s or friend’s involvement in a patient’s care when the patient agrees or does not object, or, when the patient is not present or cannot agree, when the professional judges it is in the patient’s best interest. A page can welcome a family member’s call, but the intake team should ask the patient what may be shared and record it. For a teen, say on the page that the care team may speak with the teen alone for part of the visit and that state law sets what is shared with parents, without promising either side more than the law allows.

Partners, schools, employers and referral payments

Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state. For an anxiety screening program, keep these points:

• Do not pay a school, an employer, a coach, a community group or an app maker per person screened or referred, and do not accept payment from a therapy group, a clinic or a company for the patients the practice sends them, without counsel’s review.
• A school or employer that hosts screening should not see individual answers or results; set out in writing who sees what, and have counsel review it. Our guide to corporate wellness program marketing covers employer programs.
• Give patients more than one option for therapy and specialist care where they exist, and tell them they can choose; our guide to patient and physician referrals covers the rules.

Privacy, pixels and ads

A booking for a visit about worry, a self-check answer or a page about panic can say something sensitive about a person’s health. Keep form answers, bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place, language settings and search terms such as “anxiety screening near me”, and should not be built from a list of patients with a diagnosis or a medicine taken from the practice’s records. Ad copy should not address the reader as a person with anxiety (“Struggling with constant panic?”); describe the service instead.

Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it.

Tone, access and patient stories

A reader who feels judged for being anxious may stay away. Present the questions as a routine part of care, use calm words, and keep out alarm: no images of a person in distress, no countdown clocks, no wording that suggests a reader is weak or to blame. Write in plain words, offer the page in the languages the practice’s patients speak, and link translated federal pages where they exist; NIMH and MedlinePlus offer pages in Spanish, and our guide to Spanish language medical marketing covers translation. The Department of Justice Guidance on Web Accessibility and the ADA explains why booking pages and forms need to work for people with disabilities, including people who use screen readers or a keyboard alone.

A patient’s story about getting help can encourage others. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. A story that says a patient’s panic went away invites that reading. Use a story only if the patient chose to share it in writing, get a signed authorization under 45 CFR 164.508, and leave out diagnoses, scores and medicine names. Our guide to patient testimonials and before and after photos covers the rules.

Illustration: two anxiety screening pages

Illustration: a page reads “Take our free 2-minute anxiety test and find out if you have an anxiety disorder. Kids too! Feel calm again fast with our proven program.” It turns a screen into a diagnosis, invites young children the Task Force has not recommended screening for, promises fast relief, says nothing about where the answers go, and gives no 988, 911 or chest pain line.

Illustration: a second page for the same practice reads “At [Practice name], we ask adults and teens a few questions about worry and stress as part of routine visits. Worry is a normal part of life; worry that does not go away is worth talking about. A clinician talks through your answers and your options with you. Ask us how your plan covers the visit. Call [phone] to book, [days and hours]. If you are in crisis, call or text 988. If you have chest pain or trouble breathing, or a life is in danger, call 911.” It says what the screen is, who it is for, who explains it and how to book, and puts the lines where a reader in trouble will see them.

Checklist before an anxiety screening campaign goes live

• Each USPSTF, HRSA, NIMH, MedlinePlus, CDC and Medicare.gov statement is quoted as written, named, linked and dated, and the USPSTF pages were checked again before launch.
• The page invites ages 8 to 64 as the USPSTF describes, does not present screening of children 7 or younger or adults 65 or older as recommended, and does not invite patients already in care.
• No page promises a diagnosis, fast relief, a cure, a prescription or a medicine, and no medicine, brand or supplement is named.
• The 988, 911 and chest pain lines are above the booking button, on flyers, in reminders, in voicemail and in every chat and front desk tool, and no tool tells a reader that a symptom is just anxiety.
• Any online self-check was approved by the practice’s clinicians, labels no one by score, shows 988 and 911 on every result screen and sends nothing to analytics or ad tools.
• The page keeps the recommendation and the coverage apart, does not promise free anxiety screening to Medicare patients, and says the practice checks coverage first.
• Any free offer states its terms at the outset, and counsel has reviewed any gift and any school, employer or sponsor arrangement.
• Reminders name no condition, score or medicine, teen reminders follow counsel’s approved method, and every message has an opt-out.
• Ads target place and search terms, not patient lists, and do not address the reader as a person with anxiety.
• Any patient story has written consent, an authorization where required and no diagnoses, scores or medicine names.

How we help

We build websites, local search, Google Ads, patient lead generation and AI front desk tools for independent practices and health businesses, including primary care, pediatric, OB-GYN, integrative and behavioral health practices. For an anxiety screening program, that means a site that builds its pages on the USPSTF, HRSA, NIMH and Medicare.gov pages as written and dated, keeps screening apart from diagnosis and both apart from coverage, gives the 988, 911 and chest pain lines where a reader in trouble will see them, keeps self-check answers out of ad tools, and answers calls and messages in a way that hands urgent ones to people at once.

Sources

• USPSTF: Anxiety Disorders in Adults: Screening (June 20, 2023)
• USPSTF: Anxiety in Children and Adolescents: Screening (October 11, 2022)
• USPSTF: Recommendations in Progress (checked October 30, 2026)
• HHS: Secretary Kennedy Announces New Appointments to U.S. Preventive Services Task Force (September 17, 2026)
• Kennedy v. Braidwood Management, Inc. (U.S. Supreme Court, decided June 27, 2025)
• HRSA: Women’s Preventive Services Guidelines (last reviewed December 2025)
• NIMH: Anxiety Disorders (last reviewed December 2024)
• MedlinePlus: Anxiety (updated October 17, 2023)
• CDC: Heart Attack Symptoms, Risk, and Recovery (October 24, 2024)
• Medicare.gov: Depression screening (checked October 30, 2026)
• Medicare.gov: Mental health care (outpatient) (checked October 30, 2026)
• Medicare.gov: Yearly wellness visits (checked October 30, 2026)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• 42 U.S.C. 300gg-13: Coverage of preventive health services
• 45 CFR 164.501: Definitions
• 45 CFR 164.502: Uses and disclosures of protected health information: General rules
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 45 CFR 164.510: Uses and disclosures requiring an opportunity for the individual to agree or to object
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7a: Civil monetary penalties
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy
• U.S. Department of Justice: Guidance on Web Accessibility and the ADA

More in Physician specialty marketing